echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Official issue extends the centralized settlement cycle of medical supplies

    Official issue extends the centralized settlement cycle of medical supplies

    • Last Update: 2021-02-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    to extend the settlement period of consumablesRecently, according to the Nanjing Municipal Medical Insurance Bureau, the Nanjing Municipal Medical Insurance Bureau issued the "City Medical Security Bureau on the promotion of medical institutions, pharmaceutical enterprises to carry out centralized procurement of medical supplies (drugs) and centralized settlement work notice" (hereinafter referred to as "Notice"), will be phased to extend the centralized settlement cycle of medical supplies."Notice" shows that, in order to alleviate the new crown pneumonia epidemic on fixed-point medical institutions and production (distribution) enterprises operating impact, the temporary medical supplies online centralized procurement, income verification library to online payment centralized settlement time of no more than 30 days, 60 days, unified extended to 3 months.The fixed-point medical institutions are required to strictly implement the requirement of extending the centralized settlement time of medical supplies (drugs) for 3 months, to do a good job of centralized settlement on-line in a timely manner, not to appear new arrears, not to occur new offline settlement behavior.According to the Notice, for the purchase of medical supplies with volume, the medical insurance fund shall advance to the fixed-point medical institutions with volume purchase in proportion to 30%-50% of the total cost, speed up the payment of the goods and realize the exchange price in volume.In principle, the advance payment shall be made to the relevant fixed-point medical institution within 2 months after the results of the volume purchase have been determined.

    hospitals and arms companies, financial pressures areAffected by the outbreak, hospital funding pressure is increasing, some tender projects are difficult to carry out normally.Recently, a device of the national general responsible person for the Cypress blue equipment said that Zhejiang, Shandong and other regional hospitals would have finished the year to start bidding, but due to the impact of the outbreak immediately stopped.According to reports, the outbreak to the local health care, finance and hospital funding brought a lot of pressure. "I've kept in communication with several deans that they're under too much financial pressure, and in order to maintain operations, the general supplies hospitals are not picked up, and tenders for medical equipment such as MRI, CT, ventilators, oxygen machines have been suspended." The above-mentioned person in charge said.According to Cypress Blue equipment statistics, Shandong, Henan, Zhejiang and other regional hospitals continue to issue a notice to terminate the purchase of medical devices.For example, according to the Luoyang Municipal Government Procurement Network of Henan Province, on April 20, a hospital in Luoyang issued the "First Termination Notice for the Purchase of Medical Equipment for 2019", and according to the News Network of the Chinese Government on April 20, the Navy's 971st Hospital issued a termination procurement announcement, saying that the procurement of related projects is now cancelled according to the actual situation.In the hospital fund pressure, unable to carry out normal bidding at the same time, the armed enterprises not only face the risk that the business can not be carried out, but also to bear the financial pressure brought about by the extension of the repayment time.Some people in the industry have pointed out that many manufacturers of the return situation is very bad, because some areas of health insurance owed to the hospital money, the hospital owes the commercial company money, the commercial company owes the upstream manufacturers money, a debt is more than half a year, pharmaceutical enterprises will generate a large number of financial costs, pressure is great. Only Jiangsu, Zhejiang and the Pearl River Delta region will be better.In addition, many equipment and equipment categories also have a recycling period, short-term repayment is impossible to talk about.

    40% of hospitals have brokenIn April, a survey of hospitals by the medical community found that in the first quarter of this year, 95 percent of hospitals surveyed saw a year-on-year decline in business and revenue. Of these, 84.8 per cent of hospital outpatients had fallen by more than 20 per cent and 39.2 per cent had experienced a funding cut-off.   At the same time, 87.3 per cent of hospitals felt that there was pressure on funding, of which 68.4 per cent of hospital managers believed that human cost expenditure was the most important expenditure on hospitals.   Liang Jialin, executive director of the China Value Medical Research Center, also said in an article recently that medical institutions faced a double pressure of falling incomes and higher spending during the outbreak, according to the Economic Observer.   At the income end, in addition to the new crown pneumonia fixed-point hospital, the vast majority of medical institutions on outpatient services to limit the flow of people, and even because of the collective infection of medical staff closed outpatient services, many patients are also worried about infection and reduce the demand for inpatient services.   At the expense side, medical institutions need to buy medical masks, eye masks, protective clothing and other protective equipment, the transformation of fever clinics, the purchase of ventilators and other treatment equipment, the construction of testing laboratories and other scientific research facilities.   The head of a fixed-point hospital in Shenzhen reported that the total investment of treatment equipment is about 30 million yuan, and the total investment of scientific research equipment is about 20 million yuan.   The impact of the epidemic is not only hospitals, hospital funding constraints will affect the entire industrial chain, the delay of the return of cash flow to the size of the circulation company pressure, in addition to the source of production enterprises can not get the purchase price, medical supplies and equipment production will also become a problem, and then the treatment of patients will also be affected by the production and procurement of supplies.   How to solve the financial pressure brought by the epidemic to the hospital has become a concern of the whole industry. (Cypress Blue
    equipment
    )
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.